It certainly looks impossible at the moment.
This time they have also gone luke warm about drugs waiting approval.
If big number of good compounds get approved and we also get Nuvaring and E4 starts
knocking at the door
it is possible.
Collective wisdom of the market is strongly against that scenario at the moment.
But markets do change.
Ann: 2019 AGM CEO's Speech, page-68
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.50 |
Change
-0.120(2.60%) |
Mkt cap ! $382.8M | |||
| Open | High | Low | Value | Volume |
| $4.60 | $4.62 | $4.47 | $280.2K | 61.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 126 | $4.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.52 | 538 | 1 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| MYX (ASX) Chart |